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Α. Περίληψη 
 
Εισαγωγή: Το σύνδρομο της μηριαιοκοτυλιαίας πρόσκρουσης είναι μια από τις 
σημαντικότερες αιτίες άλγους του ισχίου σε νέους ενήλικες. Χαρακτηρίζεται από μη 
φυσιολογική επαφή της κεφαλής του μηριαίου και της κοτύλης. Η χρήση της αρθροσκόπησης 
του ισχίου ως θεραπεία έχει αναπτυχθεί πολύ τα τελευταία χρόνια λόγο των μειωμένων 
επιπλοκών σε σύγκριση με άλλες χειρουργικές τεχνικές.  
Σκοπός: Σκοπός της εργασίας είναι να αξιολογηθούν τυχαιοποιημένες ερευνητικές μελέτες 
που συγκρίνουν την αρθροσκόπηση του ισχίου με άλλες θεραπευτικές προσεγγίσεις για την 
αντιμετώπιση του συνδρόμου.  
Μεθοδολογία: Ελέγχθηκαν οι ηλεκτρονικές βιβλιοθήκες των Pubmed, Cochrane Library, 
Science Direct, Google scholar και το αρχείο των Clinical trials των Ηνωμένων Πολιτειών από 
το 2008 έως σήμερα. 16 άρθρα εμφανίστηκαν από τα οποία κρίθηκαν κατάλληλα για να 
συμπεριληφθούν στην μελέτη τα 5. Για την αξιολόγηση των τυχαιοποιημένων κλινικών 
μελετών χρησιμοποιήθηκε το CONSORT Checklist 
Αποτελέσματα: Μια μελέτη δεν δημοσίευσε τα αποτελέσματα της δοκιμής και αξιολογήθηκε 
μόνο για τα υπόλοιπα κριτήρια. Δύο από τις πέντε δοκιμές πέτυχαν μέτρια σκορ (21/37 και 
20/37) ενώ οι δύο άλλες πολύ υψηλά (31/37 και 30/37) 
Συμπεράσματα: Παρόλο που ο αριθμός των τυχαιοποιημένων κλινικών μελετών για την 
σύγκριση της αρθροσκόπησης με άλλες θεραπείες είναι ακόμα περιορισμένος τα 
αποτελέσματα τα οποία βασίζονται στο CONSORT checklist ήταν πάνω από το μέτριο, 
δείχνοντας από μέτρια έως μεγάλη συμμόρφωση. 
Λέξεις κλειδια: Μηριαιοκοτυλιαία, πρόσκρουση, αρθροσκόπηση, ισχίου, τυχαιοποιημένη, 
δοκιμή 
 
 
 
A.Abstract 
 
Introduction: Femoroacetabular impingement syndrome is an important cause of hip pain in 
young adults. It is characterized by excess contact between the femoral neck and head and the 
anterior rim of the acetabulum.  
Purpose: The purpose of this study is to assess the reporting quality of randomized controlled 
trials (RCTs) for Hip Arthroscopy effectiveness, in Femoroacetabular Impingement, compared 
to other therapeutic methods. 
Methods: Electronic databases of MEDLINE (Pub Med), Cohrane Library, Science Direct, 
Google scholar and United States Clinical trials registration from 2008 until today. From 16 
scientific papers, 5 were selected as appropriate for the study. For the assessment of the 
randomized controlled trials the CONSORT Checklist was used assessing the report of the 37 
key terms. 
Results: One study was not reporting results yet but in the rest of the sections complied with 
the checklist in 21 out of the 25 items. Two out of five of the trials achieved moderate score 
(21/37 and 20/37) and two trials achieved high scores (31/37 and 30/37). 
Conclusions: Although there are limited RCT’s, that compare hip arthroscopy to other 
treatments for FAI, the results based the CONSORT checklist have been more than adequate 
indicating moderate to high compliancy. 
Key words: Femoroacetabular, impingement, arthroscopy, hip, randomized, trial 
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B. Introduction 
 
 Femoroacetabular Impingement (FAI) syndrome is a recently described pathology of 
the hip and a cause of hip pain in young adults (1). It is a result of shape and size mismatch 
between the femoral head-neck and the acetabulum. There are two types of FAI: cam and 
pincer. Cam type, where the morphology of femoral neck-head junction is thicker and with 
insufficient concavity and pincer type, where acetabulum extends beyond its normal depth and 
over-covers the femoral head (2). Many patients have a combination of these two types of 
impingement (mixed type). Both types are range of movement related disorders and they are 
characterized by symptoms, clinical signs and imaging findings (3). The repetitive compressive 
and shear forces within the joint can cause damage to the acetabular labrum and cartilage, 
which is believed that can lead to hip osteoarthritis (OA) (2,4). Alpha angle greater than 83 
degrees has an odds ratio 9.66 for the development of hip osteoarthritis within 5 years follow 
up (6). 
 Hip osteoarthritis is an important factor of reduced quality of life and high healthcare 
costs (5). Current concepts for the treatment of FAI are surgical and non-surgical approaches. 
Conservative treatment involves physiotherapy, hip corticosteroid injections and anti-
inflammatory drugs (7). The surgical approaches are either open or arthroscopic. Regardless 
of the technique used the recommended surgical intervention includes the correction of bony 
anomalies through osteoplasty, as well as debridement or repair of chondral, labral, and soft 
tissue defects (8). Open approaches consist by either the Safe Surgical Dislocation approach 
described by Ganz in 2001(9) and the mini-open anterior approach of the hip described by 
Hartmann in 2009 (10). The arthroscopic surgery to treat FAI (11,12) is an increasing trend 
and is performed at a growing rate worldwide the last decade (13). Initially, open surgery was 
the most frequently used method to treat FAI, but since many case series published positive 
outcomes from hip arthroscopy for FAI (14,15), hip arthroscopy is used more often. Hip 
arthroscopy proves to be safer, with less complications and a shorter recovery time than open 
surgery (16). Until few years ago there was minimum evidence from randomised controlled 
trials (RCTs) that compare hip arthroscopy with other interventions (17). RCTs can help 
clinicians to clear out whether arthroscopic surgery of the hip has a beneficial effect on patient’s 
symptoms or can prevent osteoarthritis. However, randomized trials can yield bias if they lack 
methodological thoroughness. The purpose of this study is to assess the reporting quality of 
randomized controlled trials (RCTs) for Hip Arthroscopy effectiveness in Femoroacetabular 
Impigment comparing to other treatments. 
 
 
 
C. Methods 
  
A search was made of English-language randomized controlled trials published in 
MEDLINE (Pub Med), Cohrane Library, Science Direct, Google scholar and United States 
Clinical trials registration from 2008 until today. To ensure the inclusion of all relevant trials, 
there was a terminology search to electronic databases defined by the following terms: 
("femoroacetabular" OR "femoro-acetabular" OR "femoro acetabular") AND (impingement 
OR "impingement syndrome") AND (arthroscopy OR arthroscopic) AND (randomised OR 
random) AND (controlled OR control) AND (trial OR trials).  
Eligibility criteria for including, clinical trials in the study, were phase III clinical trials 
that compare hip arthroscopy surgery to any other possible treatment for femoroacetabular 
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impingement. This included physiotherapy, anti-inflammatory drugs, hip injections, open 
surgery and/or navigated surgery. Studies should compare patient of FAI with no previous  
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surgery of the hip and not established osteoarthritis of the hip. Studies eligible for assessment 
were not limited to blinding of the participants and to follow up of the patients.  
The assessment of the randomized controlled trials conducted with the help of the 
CONSORT Checklist. The CONSORT Checklist is a worldwide used assessment tool that 
helps to improve the reporting quality of randomized control trials (RCTs). The latest version 
described by Schulz et al (18), in 2010, updates the reporting guidelines based on the latest 
methodological evidence and accumulating experience. It includes a checklist of 25 items 
categorized in 6 sections: “Title and Abstract”, “Introduction”, “Methods”, “Results”, 
“Discussion” and finally “Other information”.  12 items are divided into a and b parts, giving 
a total of 37 points to score per paper. All items were investigated in terms of whether they 
were reported and not whether they were actually carried out during the trial. An item was 
characterised with a “yes” if it was clearly reported and with a “no” if it is partially reported or 
not reported at all.  
Data were analysed using Microsoft Excel. The total quality of the reporting score on 
the CONSORT checklist was calculated as a proportion of the “yes” rated applicable items 
with a possible range of 0 to 37 points. For every negative answer the word “no” was applied.  
 
 
D. Results 
 
From the Medline (Pubmed) search, 16 articles were listed. From them, only 4 of them 
were suitable for this study (19-22) (6 studies were only describing the protocol, 2 were 
feasibility studies, 3 were review studies and 1 was not comparing arthroscopic surgery for 
FAI, but conservative treatments). One of the four eligible for inclusion studies (21) was not 
published with results (although this was not highlighted in the title of the study) but finally 
was picked off for assessment, to the point that it was concluded, because of lack of any other 
completed clinical trials. One more study, eligible for inclusion, was found from clinical trials 
registration and Google scholar (23). No other completed clinical trials were found that could 
be included in the analysis in the study. Additional search from 2005, when the first 
arthroscopic treatment for FAI was reported (12), did not provide more clinical trials than the 
initial search (Figure 1). The causes may be attributed to the recently described 
pathophysiology of femoroacetabular impingement and the even more recent development of 
hip arthroscopy for FAI. This specificity makes the development of this study, the first that 
assess the quality of the clinical trials for FAI with the CONSORT statement. 
 
 
 
Records identified 
through database search: 
17 
5 Eligible RCT studies 
4 Completed
1 Study published with no 
final results 
Excluded:
6 studies for RCT protocol
2 feasibility studies
3 review studies 
1 comparing conservative 
treatments
Figure 1. Flow chart of the selection process 
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From the eligible trials two were examining the effectiveness of hip arthroscopy, 
compared to conservative treatment (drugs, hip injections, physiotherapy) (19,23), one 
compared to physical therapy alone (22), one compared hip arthroscopy with arthroscopic 
lavage of the hip alone (21) and the final one compared the classic hip arthroscopy with the 
computer navigated procedure (20). 
 Following the steps of the consort statement assessment, the “Title and Abstract” 
category in all of the studies concluded the identification as a randomised trial in the title. The 
structured summary of the trial was following the appropriate sequence in all studies except 
the one made from the FIRST investigators (21) that is not completed yet and is not reporting 
results and conclusions (even that the article was published in 2015).  
In the “Introduction” category the background and the objectives were examined. The 
explanation of the rationale and the background, that the study was based on, explained in all 
studies along with specific objectives and hypotheses.  
According to the date the trials were published, the first study that was assessed was 
published (23) in 2013 (Figure 2). “Methods” is the biggest part of the CONSORT Checklist. 
In this trial, the design was based on a parallel, randomised intervention model. No changes in 
eligibility criteria was made but the sample size and the duration of the follow up changed. 
From 2 years, the follow up ended in 6 months and the size of the sample from the starting 140 
patients ended up in 10. The eligibility criteria for participants and the places and time where 
the data collected were reported also. HOS (Hip Outcome Score) was the primary outcome 
measures and SF-12, LEFS (Lower extremity functional scale), MHHS (modified Harris hip 
score), NAHS (Non-arthritic hip score) and range of movement were the secondary measures. 
The sample size was determined with statistical power of 80% and 0.05 alpha error rate to 
detect a moderate effect size of 0.5 standard deviation. All interventions were explained with 
detail but there was no explanation about the mechanism and the method used to generate the 
random allocation sequence and the type of randomization of the patients. The random 
allocation sequence has been made by two surgeons and during the trial there was no blinding. 
 
 
 
 
 
In section “Results” from a total of 280 patients at the beginning, only 13 participated 
and out of them only 10 were analysed. No dates were defining the periods of recruitment and 
no information about the end of the trial was given. Baseline data and demographics of the 
Figure 2. 
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participants was presented. The participants in each group were analysed by original assigned 
groups. The confidence interval was set in 95% and for each group the primary but not all the 
secondary outcomes were analysed (range of motion wasn’t analysed). Harms and unintended 
effects were mentioned but no other analysis was performed. 
 Trial limitations were presented in “Discussion” section, together with the reasons why 
the trial failed to reach the number of participants that required and of course generalisability 
was not applicable. 
Registration number was not published, although there was a registry in United States 
clinical trials registry Library. The full protocol of the trial was available but not any sources 
of founding were mentioned. 
The next eligible trial was published in 2015 (21) (Figure 3). As mentioned before this 
was the fifth trial that participated in the study and can only be assessed for sections that are 
published. Results will be published in the near future.  
 
 
 
 
 
 
  
 In section of “Methods”, the design of the trial was not described but in the trial registry 
page the term “parallel” can be found. Eligibility criteria mentioned in detail and remained the 
same during the trial. Dates, settings, and locations where the data collected were also included. 
The intervention in each group was presented in detail with pre-specified primary and 
secondary outcome measures. Primary outcome measures were using the Visual Analog Scale 
(VAS) while for the secondary outcome measures HOS, SF-12, iHOT-12 (International Hip 
Outcome Tool), EuroQol-5D, adverse events, cost and urinary (and sexual) function were 
measured. The randomisation was made by centralized 24-hour computerized system that 
allows for automated, internet based allocation patients to the control or intervention group in 
random block sizes of 4 and 8 prior to intervention. Patients, outcomes assessors and data 
analysts were blinded. All analyses were made according to intention to treat principle and the 
statistical was presented in detail.  
 The category of “Results” cannot be assessed in this trial but some information from 
the “Discussion” and “Other” topic was available. Some of the trial limitations included the 
Figure 3. 
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unavailability of the surgeons to be blind. Registration number of the trial was given, together 
with the access to the full trial protocol and funding sources.  
 The third trial assessed was published in 2016 (20) (Figure 4). In this trial, the classic 
hip arthroscopy for FAI was compared with the navigated method. Description of the trial was 
included and together there were information about eligibility criteria for the patients, the 
sample size, the interventions for each group, the similarity between the interventions and pre-
specified primary and secondary outcomes. The randomisation type was tailored block based 
but neither the method used to generate the random allocation nor the mechanism (steps of 
concealment) was presented. The statistical method and additional analyses was sufficiently 
described.  
 
 
  
 
 
 In “Results” section the trial didn’t include any follow up information. The primary and 
secondary outcomes and results for each group were analysed in a 95% confidence interval but 
no subgroup or adjusted analyses performed. The participant flow was mentioned (despite not 
in a diagram) with loses and exclusions alongside with baseline data and demographics.  
 The trial had limitations that the writers included in the “conclusion” topic. All 
participants were male, the range of movement assessment was computer simulated, the 
surgeries performed by a single surgeon, in supine position and there was no assessment of the 
clinical value of the interventions. There was an interpretation consistent between harms and 
benefits but no discussion made about generalisability. The registration number and the 
protocol of the trial was not provided. While the sources of founding were mentioned.  
 The forth trial (22) (Figure 5) was between patients who treated with hip arthroscopy 
or physiotherapy. The writer describes in the part of “methods” the design of the trial, the 
eligibility criteria for participants and the data collection settings. The intervention in each 
group was described in detail in the study protocol and the same apply for the outcomes of the 
trial (primary and secondary). The primary outcome was measured with the HOS scale, while 
the secondary outcomes with the GRC and the iHOT-33. The sample size was determined 
based on power 80% and the randomization was performed electronically by an independent 
person in blocks of 2 or 4. The mechanism of the random allocation was mentioned and blinded 
were the assessors. Statistical methods for the comparison of groups outcomes along with 
additional sensitivity analyses were also reported. 
 The participant flow was described with a diagram (including losses and exclusions) 
and baseline data was presented. During the trial, many patients decided to change group from 
physical therapy to surgery. The analysis of the outcomes was made in both the original 
Figure 4. 
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randomization and based on the type of the final intervention. Harms and unintended effects 
were also presented.  
 The limitations of the trial were mentioned and they were the high rate of crossover, no 
masking of the therapists, the one sight that the trial took place and a single surgeon, the low 
final number of the physical therapy group and that the sample was consisted only by military 
population. These were the reasons why the writer admitted that no generalizability could be 
applied. The full trial protocol could be accessed through the trials registration number but the 
role of the founders wasn’t specified.  
 The final trial (19) (Figure 6) was 23 centres, assessor-blinded randomised trial that 
was published in 2018. During the trial design, no changes to methods and outcomes measures 
took place. The eligibility criteria along with way the sample size determined was presented. 
The statistical methods for the analysis of the outcomes in both groups were described 
thoroughly. Unfortunately, the mechanism and the type of randomisation were not available 
and the same applies for the person or persons who generated the random allocation. 
 
 
 
 
 
 In this big multi-centre trial, in the “results” section all the criteria of the checklist were 
met. The participant flow (with a diagram), the way the recruitment of the patients took place, 
the baseline data and analysis of the results were all published in the study. The limitations of 
the trial were also described. The participants and the treating clinicians were not blinded to 
treatment allocation, there was no control group and there was a delay in the time the surgery, 
Figure 5. 
Figure 6. 
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in many patients, took place. The last one resulted in the follow up examination (12 months 
after randomization) some patients not to have enough time to recover from the surgery. During 
the discussion parameters that should have been added to the trial were reported so that it could 
be generalised. The interpretation of the results was consistent with the trials hypothesis. The 
trial registry number was published and the full trial protocol could be reached through that. 
The sources of founding were reported but there was no role for the founders in the trial. 
 
Item 
No 
Klaus et 
al (2013) 
FIRST 
Team 
(2015) 
Houcke et al 
(2016) 
Mansell et 
al (2018) 
Griffin et al 
(2018) 
Proportion 
1a Yes Yes Yes Yes  Yes  5/5(100%) 
1b Yes  No Yes Yes Yes 4/5(80%) 
2a Yes  Yes Yes Yes Yes 5/5(100%) 
2b Yes  Yes Yes Yes  Yes  5/5(100%) 
3a Yes Yes No Yes Yes 4/5(80%) 
3b Yes Yes No No No 2/5(40%) 
4a Yes Yes Yes Yes Yes 5/5(100%) 
4b Yes Yes No Yes Yes 4/5(80%) 
5 Yes Yes Yes Yes No 4/5(80%) 
6a Yes Yes Yes Yes Yes 5/5(100%) 
6b No No No Yes No 1/5(20%) 
7a Yes Yes Yes Yes Yes 5/5(100%) 
7b No No No No Yes 1/5(20%) 
8a No Yes No Yes Yes 3/5(60%) 
8b No Yes Yes Yes No 3/5(60%) 
9 No Yes No Yes No 2/5(40%) 
10 No No No Yes No 1/5(20%) 
11a No Yes No Yes Yes 3/5(60%) 
11b No Yes Yes Yes No 3/5(60%) 
12a Yes Yes Yes Yes Yes 5/5(100%) 
12b Yes Yes Yes Yes Yes 5/5(100%) 
13a No N/A Yes Yes Yes 3/4(75%) 
13b Yes N/A Yes Yes Yes 4/4(100%) 
14a No N/A No Yes Yes 2/4(50%) 
14b No N/A Yes Yes Yes 3/4(75%) 
15 Yes N/A Yes Yes Yes 4/4(100%) 
16 Yes N/A Yes Yes Yes 4/4(100%) 
17a Yes N/A Yes Yes Yes 4/4(100%) 
17b No N/A No No Yes 1/4(25%) 
18 No N/A No Yes Yes 2/4(50%) 
19 Yes N/A No Yes Yes 3/4(75%) 
20 Yes Yes Yes Yes Yes 5/5(100%) 
21 No N/A No No Yes 1/4(25%) 
22 No N/A Yes No Yes 2/4(50%) 
23 No Yes No Yes Yes 3/4(75%) 
24 Yes Yes No Yes Yes 4/5(80%) 
25 No Yes Yes No Yes 3/5(60%) 
Total 20/37 21/25 21/37 31/37 30/37  
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E. Conclusions 
 
 The CONSORT checklist does not actually assess the quality of the methodology of a 
RCT, but rather assess the reporting of key items that are crucial in determining the validity 
and quality of the RCT. The CONSORT checklist was developed as a guideline, not as an 
actual scale for assessing methodology of an RCT. A well-designed and well-reported RCT 
should meet all of the criteria of the CONSORT statement. With adequate reporting, readers 
will understand what was actually done, rather than assume what was done.  
 There is no evidence that the failure to mention methodological details equates to the 
lack of methodological knowledge or skills: a method of a trial that is not reported does not 
mean actually that it has not been performed. The reporting of methodological aspects of RCTs 
does not necessarily reflect the conduct of the trial. The responsibility for reporting lies not 
only with the authors. Peer reviewers and editors are at fault for not insisting on complete 
description of the studies as dictated by the CONSORT statement.  
 In the present study, we assessed the quality of reporting of randomized controlled trials 
that compared the Hip Arthroscopy with other therapeutic methods for the treatment of 
Femoroacetabular Impingement published from 2008 to 2018. During our search, we 
discovered that there are limited RCT’s that compare the hip arthroscopy with other therapies 
for FAI. This is a result of the recently described pathology of femoroacetabular impingement 
and the even more recent development of hip arthroscopy for FAI.  
 All RCT’s reported satisfactorily on many important items (i.e. structure of the RCT, 
scientific background, eligibility criteria, outcome measures, sample size calculation, statistical 
methods used to compare groups, participant flow, baseline data, intention-to-treat analysis and 
precision of measurement and limitations of the studies), making it easy for any reader to 
determine the quality and validity of results without needing to make various assumptions.  
 Compliance was poorest for items relating to randomization (60%), implementation of 
randomization (40%), allocation concealment mechanism (20%) and generalisability 
(25%). Good randomization protocols aim to produce treatment groups that are comparable 
and have an equal distribution of both known and unknown confounders. Achieving patient 
randomization suitable for a clinical trial is a complex issue. The fact that items related to the 
previous topics were poorly adhered to, highlights the need for further education regarding this 
aspect of trial design. 
 Two out of five of the studies achieved moderate score (21/37 and 20/37), two studies 
achieved high scores (31/37 and 30/37) and the study that was not yet completed 21 out of 25 
items, suggesting that many journals have adopted the CONSORT checklist and have improved 
levels of compliance in their trial reports. There are good evidence in the literature that the 
Chart 1. 
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adoption of CONSORT statement improves the quality of both the conduct and reporting of 
trials in journals that have taken the decision to make it a requirement for submission 
acceptance. Researchers also need to design research with full understanding of the CONSORT 
reporting guidelines and full consideration of items whose reporting quality is low.  
 In conclusion, although there is a limited number of RCT’s regarding hip arthroscopy 
for FAI, the results based the CONSORT checklist have been more than adequate. During a 
period of rapid transition in the healthcare delivery system (where cost and effectiveness of 
every treatment matters more and more) and especially during a period of new therapeutic 
modalities, higher quality reports are likely to improve RCT interpretation, minimize biased 
conclusions, and ultimately facilitate decision-making about treatment effectiveness.  
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